Fundraising Fox

Scott Gottlieb

Investor

Special Partner at New Enterprise Associates (NEA)

Chevy Chase, Maryland

Writes $2M – $50M checks · typically $25M

About

Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.

Invests in

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Experience

  1. New Enterprise AssociatesPartnercurrent2007 — presentChevy Chase, MD
  2. American Enterprise InstituteSenior Fellowcurrent2003 — presentWashington D.C. Metro Area
  3. National Academy of MedicineElected Membercurrent2018 — presentWashington D.C. Metro Area
  4. PfizerIndependent Member of the Board of Directorscurrent2019 — presentBoston, MA
  5. UnitedHealth GroupIndependent Member of the Board of Directorscurrent2025 — presentMinnesota, United States
  6. IlluminaChairman of the Board of Directorscurrent2020 — presentSan Diego, California, United States
  7. Xaira TherapeuticsBoard Membercurrent2024 — presentSan Francisco, California, United States
  8. Comanche BiopharmaBoard Membercurrent2024 — presentBoston, Massachusetts, United States
  9. ResilienceBoard Membercurrent2020 — presentBoston, Massachusetts, United States
  10. AetionBoard Membercurrent2019 — presentNew York, United States
  11. Tempus AIIndependent Member of the Board of Directorscurrent2019 — presentChicago, Illinois, United States
  12. FDACommissioner2017 — 2019White Oak, MD
  13. U.S. Department of Health and Human Services (HHS)Member Federal Health IT Policy Committee2013 — 2017Washington, DC
  14. Society of Hospital MedicineMember of the Policy Board2011 — 2017
  15. Daiichi Sankyo, Inc.Independent Member of the Board of Directors2015 — 2017Livingston, NJ
  16. American Pathology PartnersIndependent Member of the Board of Directors2012 — 2017Denver, CO
  17. NYU Langone HealthClinical Assistant Professor2011 — 2017New York, NY
  18. GlaxoSmithKlineMember of the Product Investment Board2010 — 2017Greater Philadelphia Area
  19. Gradalis, Inc.Independent Member of the Board of Directors2015 — 2017Dallas, TX
  20. MedAvanteIndependent Member of the Board of Directors2007 — 2017Princeton, NJ

Education

  1. Icahn School of Medicine at Mount SinaiResident, Internal Medicine Residency Program1999 — 2002
  2. Icahn School of Medicine at Mount SinaiDoctor of Medicine (MD), Medicine1995 — 1999
  3. Wesleyan UniversityBA, Economics1990 — 1994

Skills & more

Board LevelHealthcare Information Technology18Health Policy81Healthcare90Strategic Planning22Policy Analysis34Public Policy49Pharmaceutical Industry28Clinical Trials7Medicare6Entrepreneurship2Strategic Communications13
+12 moreNonprofitsStrategyPublic HealthPublic SpeakingCoalitionsResearchGovernmentLegislative RelationsPolicyPublic RelationsPoliticsMedicine

From Scott's professional profile.

Same school

Shared employers

Deals · 1

Tempus LabsBoard seat

via New Enterprise Associates (NEA) · filed Oct 2022 · $10M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at New Enterprise Associates (NEA)